Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn C Hartmann

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
Nucleic Acids Research|April 29, 2015
TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancerJeremy Chien, Hugues Sicotte, Jian-Bing Fan, et al.
The Breast Journal|January 15, 2009
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007Gordon F Schwartz, Kevin S Hughes, Henry T Lynch, et al.
Cancer Research|October 25, 2013
APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinomaBrandon Leonard, Steven N Hart, Michael B Burns, et al.
Plos One|February 6, 2013
Inherited variants in regulatory T cell genes and outcome of ovarian cancerEllen L Goode, Melissa DeRycke, Kimberly R Kalli, et al.
JCO Oncology Advances|April 1, 2026
Long-Term Survival in High-Grade Serous Ovarian Cancer Compared With the General US Population: A 30-Year Landmark AnalysisLuigi A De Vitis, Melissa C Larson, Hunter J Atkinson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 5, 2011
Assessment of hepatocyte growth factor in ovarian cancer mortalityEllen L Goode, Georgia Chenevix-Trench, Lynn C Hartmann, et al.
Cancer Immunology Research|April 26, 2014
Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcomeBridget Charbonneau, Kirsten B Moysich, Kimberly R Kalli, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
Nucleic Acids Research|April 29, 2015
TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancerJeremy Chien, Hugues Sicotte, Jian-Bing Fan, et al.
The Breast Journal|January 15, 2009
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007Gordon F Schwartz, Kevin S Hughes, Henry T Lynch, et al.
Cancer Research|October 25, 2013
APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinomaBrandon Leonard, Steven N Hart, Michael B Burns, et al.
Plos One|February 6, 2013
Inherited variants in regulatory T cell genes and outcome of ovarian cancerEllen L Goode, Melissa DeRycke, Kimberly R Kalli, et al.
JCO Oncology Advances|April 1, 2026
Long-Term Survival in High-Grade Serous Ovarian Cancer Compared With the General US Population: A 30-Year Landmark AnalysisLuigi A De Vitis, Melissa C Larson, Hunter J Atkinson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 5, 2011
Assessment of hepatocyte growth factor in ovarian cancer mortalityEllen L Goode, Georgia Chenevix-Trench, Lynn C Hartmann, et al.
Cancer Immunology Research|April 26, 2014
Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcomeBridget Charbonneau, Kirsten B Moysich, Kimberly R Kalli, et al.
Pageof 15